CommercialCoverageLow impact
Auditory Brainstem Implant
Blue Cross & Blue Shield of Mississippi·MS · Neurosurgery, ENT (Ear, Nose & Throat)·Medical Policy
We identified it
Jun 20, 2026
Summary
The Auditory Brainstem Implant policy was updated to reflect current FDA-approved devices. Coverage remains limited to unilateral implants for individuals 12+ with neurofibromatosis type 2 who are deaf from bilateral auditory nerve tumor removal. All other uses remain investigational.
Action Required
Review current auditory brainstem implant claims to ensure they meet coverage criteria: patient must be 12+ years old with neurofibromatosis type 2 and deaf from bilateral tumor removal. Ensure only unilateral implants are billed as covered services - bilateral implants and penetrating electrode types will be denied as investigational.